MMSIMERIT MEDICAL SYSTEMS INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $1.5B
- 12% YoY
- Operating margin
- 12.2%
- 6.2% YoY
- EBITDA
- $308M
- 19% YoY
- Market cap
- $5.2B
- Employees
- 7,500
- $202K revenue each
- Net debt / EBITDA
- 0.8×
- $234M net debt
- AI in 10-K
- 2.3
- mentions per 10K words
Takeover score 1 of 13
Fixable underperformance 0 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo231% of net incomeCash flow under 80% of net income
- Dilutive SBCNo3% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo18% of assetsOver 40% of assets
- Shareholder dissentNo—Any vote under 80% support
Buyer economics 1 of 4
- Low revenue per employeeYes$202K · 13th pctBottom quartile of its SIC industry
- Quiet on AINo2.3 per 10K words · 60th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo0.8× EBITDA net debtMore cash than debt, positive EBITDA
- Buyout-sizedNo$5.2B market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$8M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | 12% |
| Operating income | $61M | $88M | $124M | $156M | $185M | 19% |
| Net income | $48M | $75M | $94M | $120M | $128M | 6.8% |
| Operating cash flow | $147M | $114M | $145M | $221M | $297M | 35% |
| Capex | $28M | $45M | $34M | $35M | $82M | 133% |
| Stock-based comp | $16M | $18M | $21M | $28M | $43M | 53% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Oct 18, 2021 | Starboard Value LP | SC 13D/A | 2.5% | Passive |
| May 27, 2020 | Starboard Value LP | SC 13D/A | 8.7% | Active |
| Jan 27, 2020 | Starboard Value LP | SC 13D/A | — | Passive |
| Jan 13, 2020 | Starboard Value LP | SC 13D | — | Passive |
Insider trading
- Open-market buys, 12 mo
- $573K · 5
- Open-market sells, 12 mo
- $8M · 8
- Net
- −$8M
Pay vs performance
No pay-versus-performance disclosure yet.